Stockreport

Sagimet soars on FDA breakthrough therapy designation for its liver disease treatment [Seeking Alpha]

Sagimet Biosciences Inc.  (SGMT) 
PDF FDA granted Breakthrough Therapy designation to denifanstat for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced live [Read more]